Medicus Pharma shares surge 21.39% intraday after promoting President Carolyn Bonner to CFO, enhancing corporate alignment and stability.

Medicus Pharma surged 21.39% intraday after announcing the promotion of President Carolyn Bonner to chief financial officer, effective immediately. The move, which combines Bonner’s roles as president and CFO, is framed as a strategic decision to enhance operational and financial integration as the company advances its clinical development programs. Dr. Raza Bokhari, executive chairman & CEO, emphasized that Bonner’s leadership since September as acting CFO has strengthened continuity and stability, aligning corporate objectives as Medicus expands its clinical pipeline. Bonner’s extensive healthcare sector experience and dual oversight of financial and corporate development initiatives likely bolstered investor confidence in the company’s governance and growth trajectory. The second news item, a generic subscription prompt, holds no relevance to the stock’s performance.